Finances
World News
Investing
Stock

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Chile prosecutes individuals alleged to have stolen babies

next post

5 Biggest Blockchain ETFs in 2025

Related Posts

Metals Focus: Gold to Average US$3,210 in 2025...

June 5, 2025

Prismo Metals Appoints Gordon Aldcorn as President

June 5, 2025

Red Metal Resources Provides Update on Results of...

June 5, 2025

Bold Ventures Announces Further Increase of Non-brokered Private...

June 5, 2025

Crypto Market Recap: DePIN Market expected to soar,...

June 5, 2025

Premier American Uranium to Acquire Nuclear Fuels, Creating...

June 5, 2025

Hempalta Announces Participation in the 2025 Canadian Climate...

June 5, 2025

Scoping Study Demonstrates Low Cost Potential (Replacement)

June 5, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

Finlay Minerals Announces Increase in Size of Non-Brokered...

June 5, 2025

Investing

Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow

June 5, 2025
Prismo Metals Appoints Gordon Aldcorn as President

June 5, 2025
Red Metal Resources Provides Update on Results of Mapping Program on Its Carrizal IOCG Property

June 5, 2025
Bold Ventures Announces Further Increase of Non-brokered Private Placement

June 5, 2025
Crypto Market Recap: DePIN Market expected to soar, Hong Kong seeks to expand its digital asset market

June 5, 2025

Disclaimer: InsightfulTraderTips.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

About us
Privacy Policy
Terms & Conditions

Copyright © 2025 InsightfulTraderTips.com All Rights Reserved.

Finances
World News
Investing
Stock

Finances
World News
Investing
Stock

Copyright © 2025 InsightfulTraderTips.com All Rights Reserved.